Real-world Effectiveness and Onset of Action of Vedolizumab as a First-line Biologic in Biologic-Naïve Patients With Ulcerative Colitis

Presented at ACG 2024

Authors:
Precious A Anyanwu
Lucinda J Van Anglen
Chiahung Chou
Marie Sanchirico
Timothy E Ritter

View Poster  View Abstract

View All